Immunological responses were assessed in 11 patients with stage IV melanoma to intranodal mature DC vaccine pulsed with peptide antigen A (one of tyrosinase, MelanA/MART-1, or MAGE-1) in a normal lymph node. The gene discussed is TYR; the disease is melanoma.